vorasidenib
servier
['vorasidenib']
vorasidenib prolonged pfs and ttni in patients with resected grade 2 gliomas with idh1/2 mutations with a tolerable safety profile, providing an alternative to watch and wait after surgery #asco23 
DAVA Oncology is a strategic consulting company that offers numerous products and services customized to fit biopharmaceutical drug development needs.